Guggenheim Capital’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-10,550
| Closed | -$384K | – | 2127 |
|
|
2021
Q2 | $384K | Sell |
10,550
-15,673
| -60% | -$570K | ﹤0.01% | 1923 |
|
|
2021
Q1 | $1.15M | Sell |
26,223
-4,295
| -14% | -$188K | 0.01% | 1322 |
|
|
2020
Q4 | $1.4M | Buy |
+30,518
| New | +$1.4M | 0.01% | 1157 |
|
|
2020
Q1 | – | Sell |
-7,783
| Closed | -$262K | – | 1847 |
|
|
2019
Q4 | $262K | Sell |
7,783
-14,020
| -64% | -$472K | ﹤0.01% | 1889 |
|
|
2019
Q3 | $817K | Sell |
21,803
-4,281
| -16% | -$160K | 0.01% | 1405 |
|
|
2019
Q2 | $1.14M | Sell |
26,084
-3,158
| -11% | -$138K | 0.01% | 1294 |
|
|
2019
Q1 | $1.25M | Sell |
29,242
-1,910
| -6% | -$81.5K | 0.01% | 1283 |
|
|
2018
Q4 | $1.4M | Buy |
+31,152
| New | +$1.4M | 0.01% | 1217 |
|
|
2018
Q2 | – | Sell |
-44,379
| Closed | -$2.05M | – | 2375 |
|
|
2018
Q1 | $2.05M | Buy |
44,379
+1,331
| +3% | +$61.4K | 0.01% | 1618 |
|
|
2017
Q4 | $1.99M | Sell |
43,048
-24,666
| -36% | -$1.14M | ﹤0.01% | 1672 |
|
|
2017
Q3 | $3.05M | Sell |
67,714
-3,473
| -5% | -$156K | 0.01% | 1368 |
|
|
2017
Q2 | $2.8M | Sell |
71,187
-2,460
| -3% | -$96.7K | 0.01% | 1379 |
|
|
2017
Q1 | $2.81M | Sell |
73,647
-6,392
| -8% | -$244K | 0.01% | 1400 |
|
|
2016
Q4 | $2.96M | Buy |
80,039
+38,127
| +91% | +$1.41M | 0.01% | 1380 |
|
|
2016
Q3 | $1.45M | Sell |
41,912
-4,448
| -10% | -$154K | ﹤0.01% | 1832 |
|
|
2016
Q2 | $1.51M | Sell |
46,360
-148,556
| -76% | -$4.83M | ﹤0.01% | 1755 |
|
|
2016
Q1 | $5.6M | Sell |
194,916
-38,221
| -16% | -$1.1M | 0.02% | 931 |
|
|
2015
Q4 | $7.79M | Sell |
233,137
-54,168
| -19% | -$1.81M | 0.02% | 843 |
|
|
2015
Q3 | $8.17M | Sell |
287,305
-64,808
| -18% | -$1.84M | 0.03% | 827 |
|
|
2015
Q2 | $14.3M | Buy |
352,113
+283,814
| +416% | +$11.5M | 0.04% | 703 |
|
|
2015
Q1 | $3.36M | Buy |
68,299
+1,825
| +3% | +$89.8K | 0.01% | 1390 |
|
|
2014
Q4 | $3.02M | Buy |
+66,474
| New | +$3.02M | 0.01% | 1429 |
|